Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001140361-23-015503

Director bought 5,000 shares at $1.55 ($7,750)

From the SEC's structured data for this filing

Trades in this filing

Jones Elaine V · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-03-29 Purchase : show line 1 in the form +5,000 $1.55 $7,750 5,142 D
Open-market purchases · 5,000 sh · avg $1.55 · $7,750
Loading xslF345X04/form4.xml…